Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (3), 195-203

PI3K Signalling: The Path to Discovery and Understanding

Affiliations

PI3K Signalling: The Path to Discovery and Understanding

Bart Vanhaesebroeck et al. Nat Rev Mol Cell Biol.

Abstract

Over the past two decades, our understanding of phospoinositide 3-kinases (PI3Ks) has progressed from the identification of an enzymatic activity associated with growth factors, GPCRs and certain oncogene products to a disease target in cancer and inflammation, with PI3K inhibitors currently in clinical trials. Elucidation of PI3K-dependent networks led to the discovery of the phosphoinositide-binding PH, PX and FYVE domains as conduits of intracellular lipid signalling, the determination of the molecular function of the tumour suppressor PTEN and the identification of AKT and mTOR protein kinases as key regulators of cell growth. Here we look back at the main discoveries that shaped the PI3K field.

Similar articles

See all similar articles

Cited by 270 PubMed Central articles

See all "Cited by" articles

References

    1. J Biol Chem. 1996 Sep 27;271(39):24048-54 - PubMed
    1. Biochem J. 1994 Mar 15;298 Pt 3:517-20 - PubMed
    1. Nat Cell Biol. 2002 Sep;4(9):658-65 - PubMed
    1. Nature. 1995 Aug 17;376(6541):599-602 - PubMed
    1. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4330-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback